Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jul 14, 2023; 29(26): 4186-4199
Published online Jul 14, 2023. doi: 10.3748/wjg.v29.i26.4186
Figure 6
Figure 6 Cumulative rates of early recurrence and survival rates of hepatocellular carcinoma. A: Risk accumulation curve of recurrence-free survival (RFS) in the training cohort; B: Survival curve of overall survival (OS) in the training cohort; C: Risk accumulation curve of RFS in the validation cohort; D: Survival curve of OS in the validation cohort; E and F: Risk accumulation curve of RFS in the alpha-fetoprotein (AFP)-negative group in the training and validation cohorts; G and H: Risk accumulation curve of RFS in the AFP-positive group in the training and validation cohorts. AFP: Alpha fetoprotein.